TG Therapeutics, Inc. TGTX

57.43 (0.09) (0.16%) as of 25 Sep
Market cap
$8.8B
P/E
18.9×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
141.97 311.00 217.51 161.68 314.76 605.43 140.44 68.90 84.72 44.89
Receivables
305.63 129.19 51.09 — 1.39 — — 0.10 0.11 0.08
Inventory
125.59 110.46 39.82 — — — — — — —
Other current assets
57.58 15.72 9.52 2.36 2.88 1.08 0.61 0.44 0.44 0.22
Total current assets
630.76 566.36 317.94 168.27 330.97 611.74 149.15 79.03 93.32 50.86
Property, Plant, Equpment (Net)
— — 0.10 0.31 0.60 0.48 0.28 0.25 0.25 0.33
Long-Term Investments
59.14 0.81 — 12.40 35.53 1.26 1.25 1.24 0.59 0.58
Goodwill and Intangible Assets (Total)
— — 0.80 0.80 0.80 0.80 0.80 0.80 0.80 0.80
Long Term Assets (Tax, Deferred)
348.00 — — — — — — — — —
Long-term assets (Other)
3.39 3.37 3.59 2.90 3.10 3.31 3.38 3.54 3.02 2.79
Total non-current assets
432.49 11.33 11.64 25.30 48.66 13.90 13.86 4.59 4.06 3.92
Total Assets
1,063.25 577.69 329.59 193.57 379.63 625.64 163.01 83.62 97.38 54.78
Notes Payable
— — — — 0.98 22.18 — 0.07 0.13 0.07
Accounts Payable
107.51 58.30 38.47 42.02 51.29 37.01 30.04 36.38 25.88 15.27
Accrued Expenses
21.85 15.19 12.17 8.43 10.17 8.46 3.80 2.26 1.80 1.39
Current Part of Debt
— — — 1.58 0.98 24.79 1.81 0.07 0.13 0.07
Current Revenue (Deferred)
21.23 11.41 0.15 — — — — 0.15 0.15 0.15
Other current liabilities
2.12 4.63 1.48 1.17 1.51 18.24 48.99 0.22 1.95 1.54
Total current liabilities
153.76 90.68 53.72 53.20 65.38 87.55 84.45 38.85 27.96 16.88
Long Term Debt (Total)
245.65 244.43 100.12 71.14 66.79 7.72 28.97 — — —
Non-current Revenue (Deferred)
8.81 12.09 6.02 0.31 0.46 0.61 0.76 2.38 2.43 2.04
Non-current Liabilities (Other)
— — — — — — 0.00 18.35 1.36 0.82
Total non-current liabilities
261.47 264.65 115.37 81.78 77.09 18.74 39.95 20.73 2.43 2.04
Total liabilities
415.23 355.33 169.09 134.99 142.48 106.29 124.40 59.58 30.39 18.91
Additional Paid In Capital
1,830.11 1,760.40 1,713.16 1,585.71 1,565.94 1,500.04 739.96 552.53 422.02 272.43
Common Stock (Net)
0.16 0.16 0.15 0.15 0.14 0.14 0.11 0.08 0.07 0.06
Retained Earnings
(1,082.01) (1,529.19) (1,552.58) (1,527.03) (1,328.70) (980.60) (701.22) (528.34) (354.86) (236.39)
Treasury Stock
100.23 8.99 0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.23
Common Equity (Total)
648.02 222.36 160.50 58.59 237.15 519.35 38.62 24.04 66.99 35.87
Shareholders Equity (Total)
648.02 222.36 160.50 58.59 237.15 519.35 38.62 24.04 66.99 35.87
Shareholders Equity and Liabilities (Total)
1,063.25 577.69 329.59 193.57 379.63 625.64 163.01 83.62 97.38 54.78
Shares (Common)
155.31 155.84 151.42 146.39 143.25 140.58 109.38 83.87 73.14 56.78
Shareholders Equity (Tangible)
648.02 222.36 160.50 57.79 236.35 518.55 37.82 23.24 66.19 35.07
Net Debt
103.68 (66.57) (117.39) (88.96) (247.00) (572.92) (109.66) (68.83) (84.59) (44.82)
Total Debt
245.65 244.43 100.12 72.72 67.76 32.50 30.78 0.07 0.13 0.07

Fold the line items

In millions of $ except per-share values · columns are period end dates